Syvart Dennen, Marty Masek, Sai Sriteja Boppudi Naga, Paul Cockrum, Ravi Kumar Paluri. "Costs of generic vs. branded nab-paclitaxel (nP) during first-line (1L) treatment of metastatic pancreatic adenocarcinoma (mPDAC) with gemcitabine + nab-paclitaxel (GnP) in a real-world commercial database.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.694